Valbiotis SA (ALVAL.PA)
EUR 1.36
(-1.59%)
EUR 1.36
(-1.59%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1 Million EUR | 89.98% |
| 2022 | 529 Thousand EUR | 25.65% |
| 2021 | 421 Thousand EUR | 34.5% |
| 2020 | 313 Thousand EUR | 9.06% |
| 2019 | 287 Thousand EUR | 127.78% |
| 2018 | 126 Thousand EUR | -1.56% |
| 2017 | 128 Thousand EUR | -20.5% |
| 2016 | 161 Thousand EUR | 847.06% |
| 2015 | 17 Thousand EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q2 | 855 Thousand EUR | 0.0% |
| 2023 Q4 | 1 Million EUR | 0.0% |
| 2023 FY | 1 Million EUR | 89.98% |
| 2022 FY | 529 Thousand EUR | 25.65% |
| 2022 Q2 | 518 Thousand EUR | 0.0% |
| 2022 Q4 | 529 Thousand EUR | 0.0% |
| 2021 FY | 421 Thousand EUR | 34.5% |
| 2021 Q4 | 421 Thousand EUR | 0.0% |
| 2021 Q2 | 373 Thousand EUR | 0.0% |
| 2020 Q4 | 313 Thousand EUR | 0.0% |
| 2020 Q2 | 418 Thousand EUR | 0.0% |
| 2020 FY | 313 Thousand EUR | 9.06% |
| 2019 Q2 | 157 Thousand EUR | 0.0% |
| 2019 Q4 | 287 Thousand EUR | 0.0% |
| 2019 FY | 287 Thousand EUR | 127.78% |
| 2018 FY | 126 Thousand EUR | -1.56% |
| 2018 Q4 | 126 Thousand EUR | 0.0% |
| 2018 Q2 | 113 Thousand EUR | 0.0% |
| 2017 Q2 | 64 Thousand EUR | 0.0% |
| 2017 Q4 | 128 Thousand EUR | 0.0% |
| 2017 FY | 128 Thousand EUR | -20.5% |
| 2016 Q4 | - EUR | 0.0% |
| 2016 FY | 161 Thousand EUR | 847.06% |
| 2015 FY | 17 Thousand EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ABIONYX Pharma SA | 221 Thousand EUR | -354.751% |
| ABIVAX Société Anonyme | 1.00 EUR | -100499800.0% |
| Adocia SA | 272 Thousand EUR | -269.485% |
| Aelis Farma SA | 53 Thousand EUR | -1796.225% |
| Biophytis S.A. | - EUR | -Infinity% |
| Advicenne S.A. | 1.74 Million EUR | 42.275% |
| genOway Société anonyme | 982.75 Thousand EUR | -2.264% |
| IntegraGen SA | 311.44 Thousand EUR | -222.685% |
| Medesis Pharma S.A. | 164.62 Thousand EUR | -510.489% |
| Neovacs S.A. | - EUR | -Infinity% |
| NFL Biosciences SA | -1.1 Million EUR | 190.65% |
| Plant Advanced Technologies SA | 1.22 Million EUR | 17.93% |
| Quantum Genomics Société Anonyme | -119.17 Thousand EUR | 943.29% |
| Sensorion SA | - EUR | -Infinity% |
| Theranexus Société Anonyme | - EUR | -Infinity% |
| TME Pharma N.V. | 91 Thousand EUR | -1004.395% |
| TheraVet SA | 123.34 Thousand EUR | -714.807% |
| Valerio Therapeutics Société anonyme | 1.00 EUR | -100499800.0% |
| argenx SE | 281.12 Million EUR | 99.643% |
| BioSenic S.A. | - EUR | -Infinity% |
| Celyad Oncology SA | 1.26 Million EUR | 20.238% |
| DBV Technologies S.A. | 1.00 USD | -100499800.0% |
| Galapagos NV | 73.97 Million EUR | 98.641% |
| Genfit S.A. | 4000.00 EUR | -25024.975% |
| GeNeuro SA | - EUR | -Infinity% |
| Hyloris Pharmaceuticals SA | 1.00 EUR | -100499800.0% |
| Innate Pharma S.A. | 1.00 EUR | -100499800.0% |
| Inventiva S.A. | 417 Thousand EUR | -141.007% |
| MaaT Pharma SA | 190 Thousand EUR | -428.947% |
| MedinCell S.A. | -6.71 Million EUR | 114.969% |
| Nanobiotix S.A. | 200 Thousand EUR | -402.5% |
| Onward Medical N.V. | 936 Thousand EUR | -7.372% |
| Oryzon Genomics S.A. | 6029.00 EUR | -16569.414% |
| OSE Immunotherapeutics SA | - EUR | -Infinity% |
| Oxurion NV | 128 Thousand EUR | -685.155% |
| Pharming Group N.V. | 51.38 Million EUR | 98.044% |
| Poxel S.A. | 2.95 Million EUR | 66.001% |
| GenSight Biologics S.A. | 1.00 EUR | -100499800.0% |
| Transgene SA | - EUR | -Infinity% |
| Financière de Tubize SA | - EUR | -Infinity% |
| UCB SA | 1.03 Billion EUR | 99.903% |
| Valneva SE | 44.46 Million EUR | 97.74% |
| Vivoryon Therapeutics N.V. | 1.00 EUR | -100499800.0% |